For children aged 0–12 with cancer, CancerFree Biotech offers the first round of testing services free of charge. Circulating tumor cells (CTCs) in the blood are cultured and drug-tested to help physicians choose cancer medication and reduce the chance of ineffective treatment.
Sources: Taiwan Centers for Disease Control (Ministry of Health and Welfare), World Health Organization, Taiwan Children's Cancer Foundation.
Just like stars in the night sky, these children shine brightly; some dazzle with radiant brilliance, while others emanate a subtle yet determined glow. Our mission is to aspire to be the guiding light in the darkness, ensuring no one loses their way. Why Little Star was founded
In cancer treatment today, most physicians assess, treat and prescribe according to cancer clinical practice guidelines. Unlike adult cancer, childhood cancer differs in the intensity and methods of treatment, the risks and outcomes of treatment, and the tolerance of side effects of chemotherapy drugs. Around 80% of pediatric cancer cases in high-income countries can be cured; with active treatment, the condition of most children can be controlled.
Precision medicine is being used to select cancer treatments, including the cultivation of circulating tumor cells (CTCs) for drug testing, aiming to reduce the chances of ineffective treatment. For the related technology, see CancerFree Biotech's EVA Select.
CancerFree Biotech Knowledge Hub
You can discuss this with your primary care physician or contact us via the provided phone number for consultation. The testing process is as follows:
Discuss with your attending physician whether the test is suitable, or call our contact number directly for a consultation.
Circulating tumor cells (CTCs) in the blood are used for the subsequent culture.
The cells are cultured in a biomimetic tumor organ culture system.
The drugs selected by the physician are tested, to reduce the chance of ineffective medication.
We have done thorough research on childhood cancer and published it as papers.
View papers →
We have compiled health education information on each cancer type, chemotherapy, radiotherapy, immunotherapy and more.
Read more →
In recent years we have held many events to support children with cancer, and we hope they can grow up happily.
See events →
We follow up with the patients who have used our services, gaining insights into the resilience of life through their stories.
Read stories →The importance of health education lies in giving people the knowledge and skills they need to make healthy lifestyle choices, prevent disease, improve their quality of life, and deal effectively with health problems.
The number of circulating tumor cells before treatment is an independent predictor of progression-free survival and overall survival in patients with metastatic breast cancer.
More (PubMed) →
Analyzing circulating tumor cells (CTCs) in patients with breast cancer that has metastasized to the brain allows us to identify and assess the relationship between CTCs and cancer metastasis.
More (PubMed) →
Culturing circulating tumor cells (CTCs) from the blood of colorectal cancer patients enables us to assess and identify these cells for diagnostic purposes.
More (PubMed) →
Cultivating circulating tumor cells (CTCs) from the blood of patients with lung cancer, breast cancer, and glioblastoma allows us to conduct DNA analysis to observe whether there are any mutated genes.
More (PubMed) →
Cultivating circulating tumor cells (CTCs) from the blood and testing their response to drugs enables personalized treatment for individuals. This approach allows for an assessment of the patient's response to treatment and provides a prognosis for their therapy outcome.
More (PubMed) →
Cultivating circulating tumor cells (CTCs) from the blood of breast cancer patients and confirming their oncogenic potential in mice allows for individual drug sensitivity testing.
More (PubMed) →
Using EVA Select for CTC culture and conducting in vitro drug testing allows us to observe the effectiveness of treatments for non-small cell lung cancer, liver cancer, and sarcoma.
CancerFree Biotech EVA Select →For more events, see CancerFree Biotech Social Welfare.
微光時分｜葉小姐
A patient's story of fighting Ewing sarcoma, a rare cancer
微光時分｜黃媽媽
A family member's story of fighting osteosarcoma
微光時分｜盧先生
A patient's story of fighting osteosarcoma
For children aged 0–12 with cancer, CancerFree Biotech offers the first round of testing services free of charge. You can discuss this with your primary care physician or contact us via the provided phone number for consultation.
Circulating tumor cells (CTCs) in the blood are cultured in a biomimetic tumor organ culture system, and the drugs selected by the physician are tested, to reduce the chance of ineffective medication.
Unlike adult cancer, childhood cancer differs in the intensity and methods of treatment, the risks and outcomes of treatment, and the tolerance of side effects of chemotherapy drugs, so precision medicine can help in choosing cancer medication.
Email littlestar@cancerfree.io, phone (02) 7752-2586 #104, service personnel Anastasia Chen, or use the form below.
You can discuss this with your primary care physician or contact us via the provided phone number for consultation. Service Personnel: Anastasia Chen.
